Innoviva (INVA) Non-Current Assets (2010 - 2026)
Innoviva (INVA) posted Non-Current Assets of $1.1 billion for Q1 2026, up 17.22% on a QoQ basis from $907.6 million in Q4 2025, and up 58.24% year-over-year from $672.4 million in Q1 2025.
Innoviva (INVA) Non-Current Assets (2010 - 2026) Analysis & Trends
Innoviva's Non-Current Assets history runs 17 years deep, the most recent figure standing at $1.1 billion for Q1 2026.
- Quarterly Non-Current Assets rose 58.24% year-over-year to $1.1 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.3 billion (up 2.58% YoY) and the FY2025 annual result came in at $907.6 million, up 21.55% from the prior year.
- Non-Current Assets was $1.1 billion for Q1 2026 at Innoviva, up from $907.6 million in the prior quarter.
- Across five years, Non-Current Assets topped out at $1.1 billion in Q1 2026 and bottomed at $59.6 million in Q3 2022.
- A 5-year average of $557.1 million and a median of $737.3 million in 2022 frame the typical range for Non-Current Assets.
- Peak annual rise in Non-Current Assets reached 5746.67% in 2022, while the deepest fall reached 90.27% in 2022.
- Innoviva's Non-Current Assets stood at $59.6 million in 2022, then advanced by 27.73% to $76.2 million in 2023, then surged by 880.3% to $746.8 million in 2024, then grew by 21.55% to $907.6 million in 2025, then gained by 17.22% to $1.1 billion in 2026.
- Business Quant data shows INVA's Non-Current Assets at $1.1 billion in Q1 2026, $907.6 million in Q4 2025, and $72.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 21.65 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 5.83 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.95 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 3.95 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.75 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.66 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 289.41 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.96 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 285.82 Mn |
| 10 | Innoviva | 1.57 Bn | 969.11 Mn | 75.83 Mn | 1.06 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.06 Bn |
| Dec 31, 2025 | 907.65 Mn |
| Sep 30, 2025 | 72.59 Mn |
| Jun 30, 2025 | 681.79 Mn |
| Mar 31, 2025 | 672.37 Mn |
| Dec 31, 2024 | 746.75 Mn |
| Sep 30, 2024 | 75.85 Mn |
| Jun 30, 2024 | 866.64 Mn |
| Mar 31, 2024 | 956.27 Mn |
| Dec 31, 2023 | 76.18 Mn |
| Sep 30, 2023 | 76.18 Mn |
| Jun 30, 2023 | 794.70 Mn |
| Mar 31, 2023 | 833.32 Mn |
| Dec 31, 2022 | 59.64 Mn |
| Sep 30, 2022 | 59.64 Mn |
| Jun 30, 2022 | 737.31 Mn |
| Mar 31, 2022 | 789.65 Mn |
| Dec 31, 2021 | 612.72 Mn |
| Sep 30, 2021 | 1.02 Mn |
| Jun 30, 2021 | 640.89 Mn |